Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Davison

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJohn R Teerlink, Marco Metra, G Michael Felker, et al.
European Journal of Heart Failure|March 16, 2010
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot studyMarco Metra, John G Cleland, Beth Davison Weatherley, et al.
European Journal of Heart Failure|September 23, 2020
Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 studySiting Feng, Satit Janwanishstaporn, John R Teerlink, et al.
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
Cardiology|October 1, 2010
Acute heart failure clinical drug development: from planning to proof of activity to phase IIIGad Cotter, Adriaan A Voors, Beth Davison Weatherley, et al.
ESC Heart Failure|March 16, 2026
Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF StudyJolie Bruno, Aziz Daghmouri, Malha Sadoune, et al.
European Journal of Heart Failure|December 18, 2024
Observational study for multiparametric assessment of cardiac congestion in outpatient worsening heart failure (EVOLUTION)Gad Cotter, Beth Davison, Philip Janiak, et al.
International Journal of Cardiology|September 20, 2021
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registryÒscar Miró, Pere Llorens, Yonathan Freund, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJohn R Teerlink, Marco Metra, G Michael Felker, et al.
European Journal of Heart Failure|March 16, 2010
Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot studyMarco Metra, John G Cleland, Beth Davison Weatherley, et al.
European Journal of Heart Failure|September 23, 2020
Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 studySiting Feng, Satit Janwanishstaporn, John R Teerlink, et al.
European Journal of Heart Failure|December 15, 2015
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial designJozef Bartunek, Beth Davison, Warren Sherman, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registryClovis Nkoke, Albertino Damasceno, Christopher Edwards, et al.
Cardiology|November 20, 2010
Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF studyOlga Milo-Cotter, John R Teerlink, Marco Metra, et al.
Cardiology|October 1, 2010
Acute heart failure clinical drug development: from planning to proof of activity to phase IIIGad Cotter, Adriaan A Voors, Beth Davison Weatherley, et al.
ESC Heart Failure|March 16, 2026
Cardiac Biomarkers Response Under Angiotensin Receptor-Neprilysin Inhibitor: A Sub-Analysis of the Natrium-HF StudyJolie Bruno, Aziz Daghmouri, Malha Sadoune, et al.
European Journal of Heart Failure|December 18, 2024
Observational study for multiparametric assessment of cardiac congestion in outpatient worsening heart failure (EVOLUTION)Gad Cotter, Beth Davison, Philip Janiak, et al.
International Journal of Cardiology|September 20, 2021
Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure: Insights from the EAHFE Spanish registryÒscar Miró, Pere Llorens, Yonathan Freund, et al.
Pageof 10